Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2236 AL 2250

Cognition and obstructive sleep apnea in Parkinson's disease: randomized controlled trial of positive airway pressure

Lajoie AC, Lafontaine AL, Kimoff RJ, Benedetti A, Robinson AR, Létourneau M, Crane J, Scanga A, Noel F, Kaminska M.

Sleep. 2025 Jul 11;48(7):zsaf038. doi: 10.1093/sleep/zsaf038.

Treating psychosis in people with Parkinson's disease

Borek LL, Friedman JH.

Expert Opin Drug Saf. 2025 May;24(5):513-518. doi: 10.1080/14740338.2025.2467813. Epub 2025 Feb 16.

Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care

Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, Suansanae T.

Int J Clin Pharm. 2025 Jun;47(3):834-843. doi: 10.1007/s11096-025-01883-6. Epub 2025 Feb 13.

Strategies for inhibiting amyloid fibrillation: Current status and future prospects

Hassan MN, Hussain M, Khan RH.

Prog Mol Biol Transl Sci. 2025;211:145-168. doi: 10.1016/bs.pmbts.2024.09.001. Epub 2025 Jan 21.

Factors responsible for alpha-Synuclein aggregation

Singh KS, Verma R, Singh N, Singh LR, Gupta A.

Prog Mol Biol Transl Sci. 2025;211:271-292. doi: 10.1016/bs.pmbts.2024.11.004. Epub 2025 Jan 25.

Modulation of conformational integrity and aggregation propensity of α-synuclein by osmolytes: Implications in therapeutic intervention of Parkinson's disease

Ahanger IA, Hajam IB, Wani OH.

Prog Mol Biol Transl Sci. 2025;211:63-87. doi: 10.1016/bs.pmbts.2024.10.006. Epub 2025 Jan 21.

Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110]

Koob AO, Shaked GM, Bender A, Bisquertt A, Rockenstein E, Masliah E.

Brain Res. 2025 Mar 15;1851:149504. doi: 10.1016/j.brainres.2025.149504. Epub 2025 Feb 13.

Update on mGlu4 modulator patents: 2017 to present

Rahman FI, Webster TM, Hopkins CR.

Expert Opin Ther Pat. 2025 May;35(5):463-475. doi: 10.1080/13543776.2025.2467679. Epub 2025 Feb 22.

Identifying Behavioral Change Techniques and Mode of Delivery in Yoga Interventions Across Five Neurological Conditions: A Scoping Review

Prajapati H, Best KL, Dhariwal A, Mortenson WB, Miller WC.

J Integr Complement Med. 2025 Jul;31(7):611-628. doi: 10.1089/jicm.2024.0536. Epub 2025 Feb 14.

Corrigendum: Immediate modulatory effects of transcutaneous vagus nerve stimulation on patients with Parkinson's disease: a crossover self-controlled fMRI study

Fu C, Hou X, Zheng C, Zhang Y, Gao Z, Yan Z, Ye Y, Liu B.

Front Aging Neurosci. 2025 Jan 30;17:1560826. doi: 10.3389/fnagi.2025.1560826. eCollection 2025.

Canonical and noncanonical autophagy: involvement in Parkinson's disease

Sakurai M, Kuwahara T.

Front Cell Dev Biol. 2025 Jan 30;13:1518991. doi: 10.3389/fcell.2025.1518991. eCollection 2025.

An Emerging Prospective of Antipsychotics for Treating Neurodegenerative Disorders

Kumar B, Sahoo A, Singhal M, Varshney G, Haldar T, Bali V.

Curr Pharm Des. 2025;31(24):1925-1938. doi: 10.2174/0113816128344910241211112452.

Therapeutic Effects and Mechanisms of Icaritin in Parkinson's Disease

Zheng C, Wu L, Luo L, Cai J, Huang Z, Tian K.

Curr Pharm Des. 2025;31(25):1983-1989. doi: 10.2174/0113816128344629250115074105.

Epigenetics Modulators as Therapeutics for Neurological Disorders

Gaba M, Sharma A, Chitranshi N, Kumar G, Virmani R, Virmani T, Gugulothu D.

Curr Pharm Des. 2025;31(19):1499-1520. doi: 10.2174/0113816128330087241030093112.

Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's Diseases

Piccirillo S, Preziuso A, Serfilippi T, Cerqueni G, Terenzi V, Lariccia V, Magi S.

Curr Neuropharmacol. 2025;23(10):1169-1183. doi: 10.2174/011570159X345397241210103538.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias